IRIS
PATRONO, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.536
AS - Asia 2.315
EU - Europa 2.064
SA - Sud America 177
Continente sconosciuto - Info sul continente non disponibili 163
AF - Africa 31
OC - Oceania 2
Totale 8.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.459
SG - Singapore 885
CN - Cina 655
UA - Ucraina 371
IE - Irlanda 312
TR - Turchia 300
SE - Svezia 259
RU - Federazione Russa 246
GB - Regno Unito 226
DE - Germania 179
VN - Vietnam 176
FR - Francia 169
IT - Italia 141
BR - Brasile 139
IN - India 111
FI - Finlandia 91
BD - Bangladesh 61
HK - Hong Kong 30
CA - Canada 29
MX - Messico 27
AR - Argentina 16
IQ - Iraq 16
ES - Italia 14
PL - Polonia 14
ZA - Sudafrica 14
NL - Olanda 11
ID - Indonesia 10
IL - Israele 9
JP - Giappone 9
BE - Belgio 7
SA - Arabia Saudita 7
JM - Giamaica 6
PH - Filippine 6
AT - Austria 5
CZ - Repubblica Ceca 5
EG - Egitto 5
EU - Europa 5
UY - Uruguay 5
VE - Venezuela 5
CO - Colombia 4
DZ - Algeria 4
HN - Honduras 4
IR - Iran 4
KR - Corea 4
PK - Pakistan 4
TW - Taiwan 4
CL - Cile 3
CR - Costa Rica 3
EC - Ecuador 3
JO - Giordania 3
MA - Marocco 3
MY - Malesia 3
NI - Nicaragua 3
RO - Romania 3
AU - Australia 2
AZ - Azerbaigian 2
BB - Barbados 2
EE - Estonia 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
OM - Oman 2
QA - Qatar 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GD - Grenada 1
GE - Georgia 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
SV - El Salvador 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 8.130
Salva come PNG Salva come JPEG
Città #
Singapore 665
San Jose 413
Jacksonville 411
Chandler 365
Dublin 310
Ashburn 207
Beijing 190
Southend 172
Izmir 147
Princeton 143
Dallas 132
Council Bluffs 113
Wilmington 105
Nanjing 102
Santa Clara 96
Los Angeles 91
Dearborn 75
Cambridge 67
Ho Chi Minh City 53
New York 48
Buffalo 46
Munich 44
The Dalles 42
Ann Arbor 41
Tongling 39
Hanoi 38
Nanchang 36
Woodbridge 36
Moscow 35
Altamura 29
Hong Kong 28
Shenyang 23
Kunming 21
Helsinki 19
Boardman 18
Houston 18
Jiaxing 18
Phoenix 18
Grevenbroich 17
Hebei 17
Washington 17
São Paulo 16
Changsha 15
Augusta 14
Orem 14
Hefei 13
Norwalk 13
Brooklyn 12
Chieti 12
Columbus 12
Redondo Beach 12
Tianjin 12
Johannesburg 11
Warsaw 11
Chicago 10
Haiphong 10
Hangzhou 10
San Mateo 10
Atlanta 9
Boston 9
Da Nang 9
Falls Church 9
Frankfurt am Main 9
Murcia 9
Tokyo 9
Baghdad 8
Chennai 8
Lanzhou 8
Montreal 8
Orange 8
Seattle 8
Brussels 7
Jinan 7
Leawood 7
Mexico City 7
Rome 7
San Francisco 7
Shanghai 7
Toronto 7
Lucca 6
Milan 6
Poplar 6
Queens 6
Querétaro 6
Stockholm 6
Amsterdam 5
Belo Horizonte 5
Denver 5
Louisville 5
Manchester 5
Turku 5
Zhengzhou 5
Bandung 4
Brno 4
Charlotte 4
Goiânia 4
Hackney 4
Hải Dương 4
Kingston 4
Montevideo 4
Totale 4.982
Salva come PNG Salva come JPEG
Nome #
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 200
Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer. 191
Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice. 177
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 175
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 171
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 165
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 156
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 146
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 146
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 139
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 138
Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 135
Insulin resistance as a determinant of platelet activation in obese women. 134
Determinants of platelet activation in human essential hypertension. 132
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 130
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 129
Aspirin, platelet inhibition and cancer prevention. 129
Increased thromboxane biosynthesis in essential thrombocythemia 127
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 126
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 126
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 126
Cyclooxygenase-2 expression and inhibition in atherothrombosis. 125
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 124
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 122
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. 121
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 120
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 119
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 118
Determinants of platelet activation in Alzheimer's disease 118
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 117
Role of Platelet Activation in Dementia 117
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 116
Effects of nabumetone on prostanoid biosynthesis in humans. 116
Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury? 116
Drugs, prostaglandins, and renal function. 116
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 116
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 115
Insulin resistance as a determinant of platelet activation in obese women 114
Antiplatelet agents in the prevention of diabetic vascular complications 112
Determinants of Platelet Activation in Heart Failure. 110
Platelet activation in obese women: role of inflammation and oxidant stress. 109
Mechanisms, consequences, and prevention of coronary graft failure 109
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 108
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 108
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 107
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 106
Nutraceuticals in diabetes and metabolic syndrome. 105
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 105
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 104
Cyclooxygenase-2 expression and inhibition in human monocytes 103
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 99
Determinants of Platelet Activation in Heart Failure. 99
Soluble CD40L as an indicator of platelet Activation in Heart Failure 98
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 97
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective 97
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 96
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 96
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 94
Insulin resistance as a determinant of platelet activation in obese women 92
Short term Vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects. 90
In vivo formation of 8-isoprostaglandin F-2 alpha and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation 90
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 90
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prosta-glandin endoperoxide synthases 87
Effects of successful weight loss or pioglitazone on thromboxane-dependent platelet activation in obese women 87
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 85
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors 79
Thromboxane biosynthesis in cardiovascular diseases 79
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 78
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man 72
Increased thromboxane biosynthesis in type IIa hypercholesterolemia 71
In vivo platelet activation in diabetes mellitus 58
Off-pump coronary artery bypass grafting: 30 years of debate 51
Platelet activation, aspirin, and cancer: From basic science to clinical trials 9
Totale 8.288
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.781
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022270 0 0 6 47 26 5 7 18 25 9 41 86
2022/2023989 81 129 80 98 89 211 57 62 125 13 19 25
2023/2024417 32 10 31 13 30 113 126 18 2 3 5 34
2024/20251.184 95 283 202 16 9 41 12 29 79 41 128 249
2025/20262.530 236 114 222 261 288 155 468 100 286 201 130 69
2026/2027294 88 155 51 0 0 0 0 0 0 0 0 0
Totale 8.288